Brief: Verve Therapeutics Q1 EPS USD -0.59
08/05/2024 12:00
May 08 (Reuters) - Verve Therapeutics Q1 net income USD -48.736 million. * Q1 collaboration revenue USD 5.695 million
- $992.16m
- $495.09m
- $32.33m
May 08 (Reuters) - Verve Therapeutics Q1 net income USD -48.736 million. * Q1 collaboration revenue USD 5.695 million